Multitarget stool DNA tests — which are becoming more popular in the United States — have shown increased sensitivity over fecal immunochemical tests (FITs) for early colorectal cancer (CRC) screening ...

A national survey finds patients want personal contact after positive cancer results, with psychosocial fears outweighing cost and transportation concerns. Pharmacy-based colorectal cancer (CRC) ...

Take your FIT test at home. Do not take your test if you can see blood in your poop or if you had a recent colonoscopy that found polyps. Huntsman Cancer Institute and University of Utah Health ...

Results from a new JAMA Network study support the large-scale use of FIT tests. The findings show that those who complete one or more fecal immunochemical test (FIT) screenings are associated with a ...

A new analysis provided “strong” support for starting fecal immunochemical test (FIT) screening at ages 40-49 rather than at the currently recommended age of 50. An exploratory initiative that offered ...

The simple addition of a deadline to a mailed invitation for fecal immunochemical test (FIT) colorectal cancer (CRC) ...

Combining mailed FIT outreach with patient navigation increased CRC screening rates among rural Medicaid enrollees. The intervention group showed a higher CRC screening completion rate compared to ...

The goal of this literature review is to provide information on both the FIT and MT-sDNA test to assist providers in advising patients on other options for colorectal cancer screening in situations ...

The analysis included 1103 people (aged 52 to 85 years) who died from colorectal adenocarcinoma between 2011 and 2017, and 9608 controls. HealthDay News — Screening with fecal immunochemical tests ...